✦ LIBER ✦

A phase 1 trial of the sulfonylhydrazine prodrug VNP40101M, a novel alkylating agent for the treatment of cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib, a novel, orally administered

✍ M. Ranson; S. Wardell 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Balsalazide: a novel 5-aminosalicylate p

✍ Wiggins, Jon Brendan; Rajapakse, Ramona 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 245 KB

S-1 plus cisplatin versus S-1 alone for

✍ Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Aki 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 155 KB

Mitomycin C and menadione for the treatm

✍ Merry Tetef; Kim Margolin; Chul Ahn; Steven Akman; Warren Chow; Lucille Leong; R 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 509 KB

Mitomycin C and menadione for the treatm

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Synthesis of a Prodrug Designed To Relea

✍ Banerjee, Ranjita; Rachid, Zakaria; McNamee, James; Jean-Claude, Bertrand J. 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 109 KB